Chromogranin A (CHGA) (Neuroendocrine Marker); Clone CHGA/1815R (Concentrate) is a recombinant monoclonal antibody specifically designed to detect Chromogranin A, a major secretory granule protein found in neuroendocrine cells throughout the body. Clone CHGA/1815R provides strong and specific cytoplasmic staining in formalin-fixed, paraffin-embedded (FFPE) tissues, making it a highly effective tool for identifying neuroendocrine differentiation in a wide range of tumors. Chromogranin A is a well-established marker used in the diagnosis of neuroendocrine neoplasms, including carcinoid tumors, pheochromocytomas, paragangliomas, pancreatic neuroendocrine tumors, and small cell carcinomas. As a recombinant clone, CHGA/1815R offers high batch-to-batch consistency, reduced background staining, and enhanced specificity. Its concentrated format allows for flexible dilution and protocol optimization to meet varying laboratory requirements. This antibody is an essential component in the immunohistochemical panel for accurate detection and classification of neuroendocrine tumors in both clinical and research settings.
Rabbit.
Recombinant full-length human CHGA protein.
CHGA/1815R
IgG, kappa.
Reacts with human. Does not react with rat. Others not known.
PC12 cells. Adrenal gland, bowel, thyroid, pancreas, or pheochromocytoma.
Recognizes the Chromogranin A protein.
Finely granular cytoplasmic.